Emerging Administration Options in Multiple Sclerosis Therapy
Learn about the emerging administration option, OCREVUS ZUNOVO, and its differences compared to OCREVUS [IV]. This session includes a demonstration of the dosing and administration of OCREVUS ZUNOVO, as well as an overview of available patient education resources for you, your practice, and your patients.
Learn about the emerging administration option, OCREVUS ZUNOVO, and its differences compared to OCREVUS [IV]. This session includes a demonstration of the dosing and administration of OCREVUS ZUNOVO, as well as an overview of available patient education resources for you, your practice, and your patients.
Learning Objectives
Awareness of the evolving understanding of disability progression in multiple sclerosis (MS) patients.
Understand OCREVUS ZUNOVO in the treatment of MS.
Gain familiarity with OCREVUS ZUNOVO dosing and administration.
Speaker(s)
Tina Vanichsarn
Angela H. Holian PharmD, BCPS, MSCS
Ambulatory Clinical Pharmacist, Neurology
University of Virginia Specialty Pharmacy, Charlottesville, VA
